Global Bio-Engineered Protein Drugs Market – Growing Due to Increasing of Chronic Disease: PMR
Industry: Healthcare
Bio-Engineered Protein Drugs Market: Global Industry Analysis and Forecast to 2020
New York, NY (PRUnderground) October 12th, 2015
Persistence Market Research has published a new report, titled ‘Bio-Engineered Protein Drugs Market: Global Industry Analysis and Forecast to 2020’. The research report highlights historical data and current statistics of the global bio-engineered protein drugs market and also forecasts development opportunities for the period between 2015 and 2020.
Increasing incidence of chronic diseases such as asthma, cancer, and diabetes is predicted to boost the growth prospects of the global bio-engineered protein drugs market during the forecast period. As per the International Agency for Research on Cancer (IARC), 12.7 mn new cancer patients were registered in 2008. The number increased to 14.1 mn patients in 2012 and is expected to increase further by 2020. The risk of complications linked with treatment by protein drugs is expected to restrict the growth of the market. However, advancements in manufacturing technologies will support the growth of the global bio-engineered protein drugs market during the forecast period.
View Full TOC: https://www.persistencemarketresearch.com/toc/3295
Proteins play a vital role in regulating biological functions such as metabolic reactions and DNA replication in the body. Genetic engineering is used to develop bio-engineered proteins. Bio-engineered proteins are commonly used to treat life-threatening diseases and injuries. The global bio-engineered protein drugs market is classified into cytokines, vaccines, monoclonal antibodies, blood products, and therapeutic enzymes.
The global bio-engineered protein drugs market is segmented on the basis of geography, products, and application. By geography, the global bio-engineered protein drugs market was collectively dominated by Europe and North America in 2014, due to the advanced biopharmaceutical industries in these regions. In Europe, Germany and France collectively hold the majority of the regional market. The Asia Pacific bio-engineered protein drug market is expected to register the highest growth rate by 2020.
Request a Brochure of this Report: https://www.persistencemarketresearch.com/samples/3295
Some of the leading players in the global bio-engineered protein drugs market are Allergan, Abbott Laboratories, Baxter International, Sanofi, Johnson & Johnson, Bayer HealthCare, Pfizer Inc., and Novartis.
About Persistence Market Research PVT. LTD.
Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.
PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We understand that each client has a unique problem statement, and address it with our strengths.
